The present invention provides an ointment with excellent drug stability and drug homogeneity. The ointment according to the present invention comprises 1 to 5 wt% of 1-[2-[(4S)-4-hydroxy-1, 2, 3, 4-tetrahydroquinolin-1-yl]-4-pyridyl]-2, 3-bis(hydroxymethyl)-6, 7-dimethoxynaphthalene.3/2 hydrate, 3 to 7 wt% of a separation-inhibiting agent, 15 to 50 wt% of a gelled hydrocarbon, a pH adjusting agent and 0.05 to 0.4 wt% of an antioxidant said ointment is excellent in drug stability and dispersion. The separation inhibiting agent is preferably polyoxyethylene(196)-polyoxypropylene(67) glycol the pH adjusting agent is preferably diisopropanolamine the antioxidant is preferably dibutylhydroxytoluene.
